Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases
Journal of Experimental Medicine · 04.11.2024 · 221 (11)
DOI: 10.1084/jem.20231152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 01.10.2024. Verfasst von Jérémie Rosain und 59 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Inserm U1163, Necker Hospital for Sick Children, Paris, France. Hauptthemen laut MEDLINE: Interferon Type I, Autoantibodies, Thymus Gland, Incontinentia Pigmenti. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rockefeller University, National Institute of Allergy and Infectious Diseases, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Human inborn errors of thymic T cell tolerance underlie the production of autoantibodies (auto-Abs) neutralizing type I IFNs, which predispose to severe viral diseases. We analyze 131 female patients with X-linked dominant incontinentia pigmenti (IP), heterozygous for loss-of-function (LOF) NEMO variants, from 99 kindreds in 10 countries. Forty-seven of these patients (36%) have auto-Abs neutralizing IFN-α and/or IFN-ω, a proportion 23 times higher than that for age-matched female controls. This proportion remains stable from the age of 6 years onward. On imaging, female patients with IP have a small, abnormally structured thymus. Auto-Abs against type I IFNs confer a predisposition to life-threatening viral diseases. By contrast, patients with IP lacking auto-Abs against type I IFNs are at no particular risk of viral disease. These results suggest that IP accelerates thymic involution, thereby underlying the production of auto-Abs neutralizing type I IFNs in at least a third of female patients with IP, predisposing them to life-threatening viral diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Inserm U1163, Necker Hospital for Sick Children, Paris, France.
- Imagine Institute, University of Paris Cité , Paris, France.
- St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
- Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP) , Paris, France.
- Clinical Immunology Department, AP-HP, Saint-Louis Hospital, Paris, France.
- Diabetes Center, University of California San Francisco , San Francisco, CA, USA.
ORCID-Profile: Jérémie Rosain, Tom Le Voyer, Xian Liu, Adrian Gervais, Laura Polivka, Axel Cederholm, Laureline Berteloot, Audrey V Parent, Alessandra Pescatore, Ezia Spinosa, Snezana Minic, Ana Elisa Kiszewski, Miyuki Tsumura, Chloé Thibault, Maria Esnaola Azcoiti, Jelena Martinovic, Quentin Philippot, Taushif Khan, Astrid Marchal, Bénédicte Charmeteau-De Muylder, Lucy Bizien, Caroline Deswarte, Lillia Hadjem, Marie-Odile Fauvarque, Karim Dorgham, Daniel Eriksson, Emilia Liana Falcone, Mathilde Puel, Sinem Ünal, Amyrath Geraldo, Corentin Le Floc'h, Hailun Li, Sylvie Rheault, Christine Muti, Claire Bobrie-Moyrand, Anne Welfringer-Morin, Ramsay L Fuleihan, Romain Lévy, Marie Roelens, Liwei Gao, Marie Materna, Silvia Pellegrini, Lorenzo Piemonti, Emilie Catherinot, Jean-Christophe Goffard, Arnaud Fekkar, Aissata Sacko-Sow, Camille Soudée, Soraya Boucherit, Anna-Lena Neehus, Cristina Has, Stefanie Hübner, Géraldine Blanchard-Rohner, Blanca Amador-Borrero, Takanori Utsumi, Maki Taniguchi, Hiroo Tani, Kazushi Izawa, Takahiro Yasumi, Sotaro Kanai
Förderung
- Rockefeller University
- National Institute of Allergy and Infectious Diseases
- Japan Agency for Medical Research and Development
- University Grenoble Alpes
- Sidra Medicine
- Chan-Zuckerberg Biohub
- Imagine Institute
- NIAID NIH HHS
Zitieren
APA
Rosain, J., Le Voyer, T., Liu, X., Gervais, A., Polivka, L., Cederholm, A., Berteloot, L., Parent, A. V., Pescatore, A., Spinosa, E., Minic, S., Kiszewski, A. E., Tsumura, M., Thibault, C., Esnaola Azcoiti, M., Martinovic, J., Philippot, Q., Khan, T., Marchal, A., …, & Kanai, S. (2024). Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases. Journal of Experimental Medicine, 221(11). https://doi.org/10.1084/jem.20231152
Vancouver
Rosain J, Le Voyer T, Liu X, Gervais A, Polivka L, Cederholm A, et al. Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases. Journal of Experimental Medicine. 2024;221(11). doi:10.1084/jem.20231152
BibTeX
@article{Rosain2024,
author = {Rosain, Jérémie and Le Voyer, Tom and Liu, Xian and Gervais, Adrian and Polivka, Laura and Cederholm, Axel and Berteloot, Laureline and Parent, Audrey V and Pescatore, Alessandra and Spinosa, Ezia and Minic, Snezana and Kiszewski, Ana Elisa and Tsumura, Miyuki and Thibault, Chloé and Esnaola Azcoiti, Maria and Martinovic, Jelena and Philippot, Quentin and Khan, Taushif and Marchal, Astrid and Charmeteau-De Muylder, Bénédicte and Bizien, Lucy and Deswarte, Caroline and Hadjem, Lillia and Fauvarque, Marie-Odile and Dorgham, Karim and Eriksson, Daniel and Falcone, Emilia Liana and Puel, Mathilde and Ünal, Sinem and Geraldo, Amyrath and Le Floc'h, Corentin and Li, Hailun and Rheault, Sylvie and Muti, Christine and Bobrie-Moyrand, Claire and Welfringer-Morin, Anne and Fuleihan, Ramsay L and Lévy, Romain and Roelens, Marie and Gao, Liwei and Materna, Marie and Pellegrini, Silvia and Piemonti, Lorenzo and Catherinot, Emilie and Goffard, Jean-Christophe and Fekkar, Arnaud and Sacko-Sow, Aissata and Soudée, Camille and Boucherit, Soraya and Neehus, Anna-Lena and Has, Cristina and Hübner, Stefanie and Blanchard-Rohner, Géraldine and Amador-Borrero, Blanca and Utsumi, Takanori and Taniguchi, Maki and Tani, Hiroo and Izawa, Kazushi and Yasumi, Takahiro and Kanai, Sotaro},
title = {Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases},
journal = {Journal of Experimental Medicine},
year = {2024},
volume = {221},
number = {11},
doi = {10.1084/jem.20231152}
}
EUVIMED